News & Updates
Filter by Specialty:
Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer
Treatment with pyrotinib in combination with trastuzumab and docetaxel (tras/doc) results in longer progression-free survival (PFS) than placebo combined with tras/doc in patients with untreated HER2-positive metastatic breast cancer, a study has shown. In addition, the safely profile of tras/doc plus pyrotinib is manageable.
Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer
10 Nov 2023
Machine learning predicts AF in heart failure patients
Use of machine learning (ML) can help pinpoint novel factors that contribute to an increased risk of atrial fibrillation (AF) in non-White patients with heart failure (HF), suggests a study. Specifically, social factors such as living alone may significantly heighten the AF risk.
Machine learning predicts AF in heart failure patients
10 Nov 2023
Does migraine increase the risk of COVID-19 in women?
Older women with a history of migraine need not worry too much about developing COVID-19, with a recent study suggesting that no significant association exists between migraine history and an increased risk of having COVID-19.
Does migraine increase the risk of COVID-19 in women?
10 Nov 2023
Subcutaneous risperidone delays impending relapse in schizophrenia
Subcutaneous injection of risperidone QM or Q2M (TV-46000) has been shown to significantly delay impending relapse in patients with schizophrenia in the phase III RISE study.
Subcutaneous risperidone delays impending relapse in schizophrenia
10 Nov 2023
Nodal staging before SBRT does not affect survival in early-stage NSCLC
Patients with early-stage nonsmall cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) have similar overall survival (OS) regardless of nodal staging, reports a study. In addition, use of SBRT has shown a steady increase over the study period.